Literature DB >> 16238105

Tissue mRNA expression in rat of newly described matrix metalloproteinases.

Fabian Bernal1, Hans-Peter Hartung, Bernd C Kieseier.   

Abstract

Matrix metalloproteinases (MMPs) comprise a large group of endoproteinases that degrade all protein components of the extracellular matrix. Functionally, MMPs contribute to several different physiological as well as pathological conditions. The number of newly described MMPs has increased in recent years, although current knowledge about their expression pattern in various tissues remains incomplete. Here we analyzed the relative mRNA expression of the most recently described MMPs--MT5-MMP (MMP-24), MT6-MMP (MMP-25), MMP-27 and epilysin (MMP-28)--in a broad selection of rat tissues using real time-PCR. MMP-24 mRNA was found to be widely expressed with predominance in the central nervous system. MMP-25 mRNA, in contrast, exhibited peak expression levels in testis, kidney and skeletal muscle, differing from previously described distribution patterns in humans. mRNAs for MMP-27 and MMP-28 were generally expressed at a lower level. All four MMPs studied were detected at higher mRNA levels in bone and kidney, suggesting a possible role of these MMPs in physiological processes within these two organs. The present study highlights the differential distribution pattern of newly described MMPs among different tissues and underlines differences in the mRNA expression between different species.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16238105     DOI: 10.4067/s0716-97602005000200016

Source DB:  PubMed          Journal:  Biol Res        ISSN: 0716-9760            Impact factor:   5.612


  8 in total

1.  LLLT actives MMP-2 and increases muscle mechanical resistance after nerve sciatic rat regeneration.

Authors:  Rodrigo Antonio Carvalho Andraus; Luciana Prado Maia; Anderson Diogo de Souza Lino; Karen Barron Parron Fernandes; Marcos Vinícius de Matos Gomes; Rinaldo Roberto de Jesus Guirro; Cláudio Henrique Barbieri
Journal:  Lasers Med Sci       Date:  2017-03-06       Impact factor: 3.161

2.  Synergistic effect of ascorbic acid and taurine in the treatment of a spinal cord injury-induced model in rats.

Authors:  Chao Chen; Qiang Yang; Xinlong Ma
Journal:  3 Biotech       Date:  2020-01-16       Impact factor: 2.406

3.  New Strategies for the Next Generation of Matrix-Metalloproteinase Inhibitors: Selectively Targeting Membrane-Anchored MMPs with Therapeutic Antibodies.

Authors:  Laetitia Devy; Daniel T Dransfield
Journal:  Biochem Res Int       Date:  2010-10-28

4.  Association Study between the Polymorphisms of Matrix Metalloproteinase (MMP) Genes and Idiopathic Recurrent Pregnancy Loss.

Authors:  Han Sung Park; Ki Han Ko; Jung Oh Kim; Hui Jeong An; Young Ran Kim; Ji Hyang Kim; Woo Sik Lee; Nam Keun Kim
Journal:  Genes (Basel)       Date:  2019-05-07       Impact factor: 4.096

Review 5.  Regulation and involvement of matrix metalloproteinases in vascular diseases.

Authors:  Matthew Amin; Sathnur Pushpakumar; Nino Muradashvili; Sourav Kundu; Suresh C Tyagi; Utpal Sen
Journal:  Front Biosci (Landmark Ed)       Date:  2016-01-01

6.  Matrix metalloproteinase 28, a novel matrix metalloproteinase, is constitutively expressed in human intervertebral disc tissue and is present in matrix of more degenerated discs.

Authors:  Helen E Gruber; Jane A Ingram; Gretchen L Hoelscher; Natalia Zinchenko; H James Norton; Edward N Hanley
Journal:  Arthritis Res Ther       Date:  2009-12-09       Impact factor: 5.156

7.  Anti-inflammatory and anxiolytic activities of Euphorbia hirta extract in neonatal asthmatic rats.

Authors:  Mingyue Xia; Ling Liu; Ruiqin Qiu; Mingli Li; Wei Huang; Gaowei Ren; Jinghui Zhang
Journal:  AMB Express       Date:  2018-11-01       Impact factor: 3.298

8.  Baclofen decreases compulsive alcohol drinking in rats characterized by reduced levels of GAT-3 in the central amygdala.

Authors:  Lucia Marti-Prats; Aude Belin-Rauscent; Maxime Fouyssac; Mickaël Puaud; Paul J Cocker; Barry J Everitt; David Belin
Journal:  Addict Biol       Date:  2021-02-01       Impact factor: 4.280

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.